CDT
Income statement / Annual
Last year (2024), Conduit Pharmaceuticals Inc.'s total revenue was $2.46 B,
and the percentage change from the previous year is not available.
In 2024, Conduit Pharmaceuticals Inc.'s net income was $198.43 M.
See Conduit Pharmaceuticals Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$2.46 B |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$1.54 B
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$922.22 M
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0.37
|
0
|
0
|
0
|
| Research and Development Expenses |
$112.37 M
|
$90,000.00
|
$111,000.00
|
$283,000.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$3.05 M
|
$2.89 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$494.60 M
|
$5.47 M
|
$3.05 M
|
$2.89 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$606.97 M
|
$5.56 M
|
$3.16 M
|
$3.17 M
|
| Cost And Expenses |
$2.15 B
|
$5.56 M
|
$3.16 M
|
$3.17 M
|
| Interest Income |
$0.00
|
$15,000.00
|
$1.98 M
|
$0.00
|
| Interest Expense |
-$38.30 M
|
$211,000.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$167,895.00
|
$1.73 M
|
$484,000.00
|
| EBITDA |
$266.46 M |
-$324,000.00 |
-$1.43 M |
-$4,381.00 |
| EBITDA Ratio |
0.11
|
0
|
0
|
0
|
| Operating Income Ratio |
0.11
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$38.52 M
|
$5.03 M
|
-$1.73 M
|
-$484,000.00
|
| Income Before Tax |
$227.94 M
|
-$535,000.00
|
-$4.89 M
|
-$3.66 M
|
| Income Before Tax Ratio |
0.09
|
0
|
0
|
0
|
| Income Tax Expense |
-$29.53 M
|
-$167,895.00
|
$374,862.00
|
$247,442.00
|
| Net Income |
$198.43 M
|
-$535,000.00
|
-$4.89 M
|
-$3.66 M
|
| Net Income Ratio |
0.08
|
0
|
0
|
0
|
| EPS |
4.88 |
-0.1808 |
-0.56 |
-0.42 |
| EPS Diluted |
4.8 |
-0.1784 |
-0.56 |
-0.42 |
| Weighted Average Shares Out |
$40.69 M
|
$33.49 M
|
$8.64 M
|
$8.64 M
|
| Weighted Average Shares Out Diluted |
$41.30 M
|
$33.95 M
|
$8.64 M
|
$8.64 M
|
| Link |
|
|
|
|
